MedPage Today on MSN
Real-World Data Show Gout Treatment Disparities
In a 10-year propensity-matched cohort study, Irene Tan, MD, of the Einstein Healthcare Network and Jefferson Health in ...
GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...
Sanofi SA ($SNY) announced an update on their ongoing clinical study. Study Overview: Sanofi and Regeneron have ...
US colleges are easing academic standards for Gen Z in the name of inclusion. Are simpler courses helping students succeed or quietly lowering the bar for industry readiness?
A large study has revealed that dozens of widely used chemicals can damage beneficial gut bacteria. Many of these substances, ...
Sotorasib is more cost-effective in treating patients with KRAS G12C non–small cell lung cancer (NSCLC) compared with ...
How Carleton is using simulation and visualization to improve training, design and human performance
At Carleton University, researchers are addressing a growing demand for advanced systems that enable learners to practice ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
A researcher has offered an explanation for how the Voynich Manuscript was created. The world's most mysterious book is ...
The condition is rare but a University of Illinois Chicago found the number of diagnosed cases jumped seven-fold from 2016 to ...
Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results